ATM/ATR
ATM (ataxia telangiectasia mutated) and ATR (ATM- and Rad3-related) are two PIKKs (phosphatidylinositol 3-kinase-like kinases) that regulate the DNA damage response (DDR) pathways.
ATM/ATR 相关产品(29)
- GC15337Berzosertib (VE-822)CAS: 1232416-25-9
Berzosertib (VE-822)是一种静脉给药的、高度强效且选择性的ATR抑制剂(IC 50 =19nM)。
- GC25372Elimusertib (BAY-1895344) hydrochloride
Elimusertib (BAY-1895344) hydrochloride is a potent, highly selective and orally available ATR inhibitor with an IC50 of 7 nM.
- GC34999(S)-CeralasertibCAS: 1352226-87-9
(S)-Ceralasertib 从专利 WO2011154737A1 中获取,化合物 II,IC50 为 2.578 nM。(S)-Ceralasertib 是一种有效的选择性亚砜亚胺吗啉代嘧啶 ATR 抑制剂,具有优异的临床前物化和药代动力学 (PK) 特征。(S)-Ceralasertib 水溶性改善,并且消除 CYP3A4 时间依赖性抑制。
- GC62108Elimusertib hydrochloride纯度: >99.50%
Elimusertib (BAY 1895344) hydrochloride 是一种有效、可口服、选择性的 ATR 抑制剂,IC50 值为 7 nM,具有抗肿瘤活性。Elimusertib hydrochloride 可用于实体瘤和淋巴瘤的研究。
- GC65327ATM Inhibitor-5CAS: 2495096-26-7
M4076 inhibits Ataxia telangiectasia-mutated (ATM) kinase activity with a sub-nanomolar potency and shows remarkable selectivity against other protein kinases, suppresses DSB repair, clonogenic cancer cell growth, and potentiates antitumor activity of ionizing radiation in cancer cell lines.
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC10196 | ETP-46464 | 1345675-02-6 | >98.00% | |
An ATR inhibitor | ||||
| GC11118 | KU 55933 | 587871-26-9 | >99.50% | |
KU 55933是一种高效且特异的ATM激酶抑制剂,能够使人类肿瘤细胞对电离辐射和化疗药物更加敏感。KU 55933在体外的IC₅₀值为13nM,K i 值为2.2nM。 | ||||
| GC12054 | KU-60019 | 925701-46-8 | >98.50% / >98.00% | |
A potent ATM kinase inhibitor | ||||
| GC14526 | CGK733 | 905973-89-9 | >99.50% | |
An anticancer compound | ||||
| GC14949 | AZ20 | 1233339-22-4 | >99.50% | |
A potent, selective ATR inhibitor | ||||
| GC15337 | Berzosertib (VE-822) | 1232416-25-9 | - | |
Berzosertib (VE-822)是一种静脉给药的、高度强效且选择性的ATR抑制剂(IC 50 =19nM)。 | ||||
| GC16489 | CP-466722 | 1080622-86-1 | >99.50% | |
An ATM kinase inhibitor | ||||
| GC10293 | VE-821 | 1232410-49-9 | >98.50% | |
An inhibitor of ATR | ||||
| GC11593 | AZD0156 | 1821428-35-6 | >98.00% | |
An ATM kinase inhibitor | ||||
| GC13491 | Mirin | 1198097-97-0 | >99.50% | |
Mirin是一种Mre11-Rad50-Nbs1(MRN)复合物抑制剂(IC 50 =12μM),能够抑制Mre11相关的外切酶活性,Mirin可抑制MRN依赖的ATM的激活。通常用于与DNA修复机制相关的癌症的研究。 | ||||
| GC16941 | AZD6738 | 1352226-88-0 | >98.50% | |
AZD6738是一种具有口服活性和高效选择性的共济失调毛细血管扩张和Rad3相关蛋白(ATR)激酶抑制剂,IC 50 值为1nM。 | ||||
| GC19047 | AZ32 | 2288709-96-4 | >99.50% | |
An ATM kinase inhibitor | ||||
| GC19468 | AZD1390 | 2089288-03-7 | >99.50% | |
AZD1390是一种新型选择性共济失调毛细血管扩张突变激酶抑制剂,能够高效穿透血脑屏障。 | ||||
| GC25372 | Elimusertib (BAY-1895344) hydrochloride | - | - | |
Elimusertib (BAY-1895344) hydrochloride is a potent, highly selective and orally available ATR inhibitor with an IC50 of 7 nM. | ||||
| GC33404 | KU 59403 | 845932-30-1 | >98.50% | |
KU59403是ATM的一个有效抑制剂,其IC50值为3nM。 | ||||
| GC33420 | BAY-1895344 | 1876467-74-1 | >99.50% | |
An ATR inhibitor | ||||
| GC34374 | BAY-1895344 hydrochloride | - | - | |
An ATR inhibitor | ||||
| GC34999 | (S)-Ceralasertib | 1352226-87-9 | - | |
(S)-Ceralasertib 从专利 WO2011154737A1 中获取,化合物 II,IC50 为 2.578 nM。(S)-Ceralasertib 是一种有效的选择性亚砜亚胺吗啉代嘧啶 ATR 抑制剂,具有优异的临床前物化和药代动力学 (PK) 特征。(S)-Ceralasertib 水溶性改善,并且消除 CYP3A4 时间依赖性抑制。 | ||||
| GC50424 | AZ 5704 | 1941214-06-7 | - | |
Potent and selective ATM kinase inhibitor; orally bioavailable | ||||
| GC62108 | Elimusertib hydrochloride | - | >99.50% | |
Elimusertib (BAY 1895344) hydrochloride 是一种有效、可口服、选择性的 ATR 抑制剂,IC50 值为 7 nM,具有抗肿瘤活性。Elimusertib hydrochloride 可用于实体瘤和淋巴瘤的研究。 | ||||
| GC64278 | RP-3500 | 2417489-10-0 | - | |
RP-3500 (Camonsertib, ATR inhibitor) is a highly potent and selective inhibitor of ATR kinase with an IC50 of 1 nM. | ||||
| GC64539 | SKLB-197 | 2713577-16-1 | >99.00% | |
SKLB-197 exerts selectively inhibition against ataxia telangiectasia mutated and Rad3-related (ATR) kinase with IC50 of 0.013 μM, also displays potent antitumor activity against ATM-deficent tumors both in vitro and in vivo. | ||||
| GC64938 | AZD-7648 | 2230820-11-6 | >99.50% | |
An inhibitor of DNA-PK | ||||
| GC65327 | ATM Inhibitor-5 | 2495096-26-7 | - | |
M4076 inhibits Ataxia telangiectasia-mutated (ATM) kinase activity with a sub-nanomolar potency and shows remarkable selectivity against other protein kinases, suppresses DSB repair, clonogenic cancer cell growth, and potentiates antitumor activity of ionizing radiation in cancer cell lines. | ||||
